PATENT CLAIM ANALYSIS

Application Number: 16196500
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "474000"]

Abstract:
The present invention includes a pharmaceutical composition, and methods of making and using, a pharmaceutical composition comprising one or more thyroid hormone(s) or analogs thereof, wherein a first portion of thyroid hormone(s) is formulated for immediate release and a second portion of thyroid hormone(s) is formulated of modified release, e.g., by forming a drug-resin particle with an ion exchange resin.

Claim (Index 27):
The pharmaceutical composition of  claim 16 , wherein the T4, the T3, or both are bound to a resin that provides a geometric dilution to aid in the ease of manufacturing and increase consistency in dosing.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 98.0
- Lexical Diversity: 1.66667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10746386', '12816287', '13844555', '13975725', '14184889']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6409529762100349
- 35 USC 102 Novelty (BERT): 0.5093800076288582
- Combined Prediction Score: 0.6277956793519172
- Mean Citation Score: 208.947694
- Max Citation Score: 228.03723
- Similarity Product: 141.2142428933358

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test